BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10828306)

  • 1. Biological activity in vitro of side-chain modified analogues of calcitriol.
    Opolski A; Wietrzyk J; Siwinska A; Marcinkowska E; Chrobak A; Radzikowski C; Kutner A
    Curr Pharm Des; 2000 May; 6(7):755-65. PubMed ID: 10828306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
    Opolski A; Wietrzyk J; Chrobak A; Marcinkowska E; Wojdat E; Kutner A; Radzikowski C
    Anticancer Res; 1999; 19(6B):5217-22. PubMed ID: 10697538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.
    Siwińska A; Opolski A; Chrobak A; Wietrzyk J; Wojdat E; Kutner A; Szelejewski W; Radzikowski C
    Anticancer Res; 2001; 21(3B):1925-9. PubMed ID: 11497279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
    Chrobak A; Radzikowski C; Opolski A
    Steroids; 2005 Jan; 70(1):19-27. PubMed ID: 15610893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells.
    James SY; Williams MA; Kelsey SM; Newland AC; Colston KW
    Biochem Pharmacol; 1997 Sep; 54(5):625-34. PubMed ID: 9337080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
    Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
    Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
    Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity.
    Suhara Y; Kittaka A; Kishimoto S; Calverley MJ; Fujishima T; Saito N; Sugiura T; Waku K; Takayama H
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3255-8. PubMed ID: 12392726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological activity of calcitriol and its new analogues -- potential therapeutic applications].
    Pełczyńska K; Jaroszewicz I; Switalska M; Opolski A
    Postepy Hig Med Dosw (Online); 2005; 59():129-39. PubMed ID: 15928596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
    Wietrzyk J; Chodyński M; Fitak H; Wojdat E; Kutner A; Opolski A
    Anticancer Drugs; 2007 Apr; 18(4):447-57. PubMed ID: 17351397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel vitamin D analog with two double bonds in its side chain. A potent inducer of osteoblastic cell differentiation.
    Mahonen A; Jääskeläinen T; Mäenpää PH
    Biochem Pharmacol; 1996 Apr; 51(7):887-92. PubMed ID: 8651937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vitamin D receptor agonists with decreased metabolic stability.
    Werz O; Wiesinger H; Steinmeyer A; Steinhilber D
    Biochem Pharmacol; 2000 Jun; 59(12):1597-601. PubMed ID: 10799658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.